GCR — Psyence Share News
0.000.00%
Last trade - 00:00- CA$40.49m
- CA$40.14m
Brief: Psyence Group Enters Into Debt-For-Equity Swap Agreement With Its Nasdaq-Listed Associate, Psyence Biomedical
Brief: Psyence Biomed Enters Into Agreement To Acquire Stake In Psylabs
Brief: Psyence Biomedical Ltd. Approved To List On Nasdaq Following Completion Of Business Combination Agreement With Newcourt Acquisition Corp
MGC Pharmaceuticals - September 2023 Quarter Activity Report
Brief: Psyence Group Announces Cantheon Capital Private Placement
Brief: Psyence Announces Business Combination Between Wholly Owned Subsidiary Psyence Biomed Corp
Brief: Psyence And Filament Health Announce Worldwide Licensing Agreement Of Psilocybin Capsule For Palliative Care
Brief: Psyence Group Announces Strategic Private Placement
Brief: Psyence Group Receives Mid-Stage Study Approval From UK Health Regulator
Brief: The Flowr Corp Announces Leadership Transition, Changes To Board Of Directors
Brief: Psyence And Filament Health Enter Into Exclusive Licensing Agreement For Natural Psilocybin Products